血清CA125在子宫腺肌病与卵巢子宫内膜异位症患者中的检测及意义  

Detection of Serum CA125 in Patients with Adenomyosis or Ovarian Endometriosis and Its Sig- nificance

作　　者：张岩[1] 那飞[1] 赵巍[1] 魏力[1] 关立华[1] 

机构地区：[1]中国医科大学附属第四医院妇科,辽宁沈阳110032

出　　处：《医学临床研究》2013年第1期41-42,共2页Journal of Clinical Research

摘　　要：【目的】探讨血清中CA125测定对子宫腺肌病及卵巢子宫内膜异位症患者的检测及意义。[A-法】选取子宫腺肌病患者56例（A组），卵巢子宫内膜异位症患者63例（B组），健康体检者45例（C组），用化学发光免疫法检测三组术前血清CA125并比较。【结果IA组、B组阳性率分别为69．64％、49．21％，均显著高于C组（P〈O．05），且A组阳性率显著高于B组，其差异均有统计学意义（P〈0．05）。【结论】血清CA125水平可作为临床子宫内膜异位症及子宫腺肌病的诊断及治疗的常用指标。[Objective] To explore the detection of serum CA125 in patients with adenomyosis or endome- triosis and its significance. [Methods] A total of 56 patients with adenomyosis（group A）, 63 patients with o- varian endometriosis（group B） and 45 healthy subjects（group C） were chosen. Serum CA125 in 3 groups was determined by chemical luminescence immunoassay method before operation. [Results] The positive rates of serum CA125 in group A and group B were 69.64% and 49.21% respectively, which were significantly higher than that in group B（ P 〈0.05）. And the positive rate of serum CA125 in group A was markedly higher than that in group B, and there was significant difference（ P 〈0.05）. [Conclusion] Serum CA125 can be used as the indicator for the diagnosis and treatment of adenomyosis and endometriosis.

关 键 词：子宫腺 CA-125抗原 血液 子宫内膜异位症 血液 

分 类 号：R711.71[医药卫生—妇产科学]